NASDAQ:SCMP
Delisted

Sucampo Pharmaceuticals Fund Forecast

etoro logo Buy SCMP
*Your capital is at risk
$18.00
+0 (+0%)
At Close: Feb 20, 2018
PDF

Red day on Tuesday for Sucampo Pharmaceuticals
(Updated on Feb 20, 2018)

Hold candidate since Feb 16, 2018

No changes to the price of Sucampo Pharmaceuticals fund on the last trading day (Tuesday, 20th Feb 2018). During the last trading day the fund fluctuated 0% from a day low at $18.00 to a day high of $18.00. The price has been going up and down for this period, and there has been a 0.28% gain for the last 2 weeks.

The fund has broken the wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $18.67. A reaction back to this level may hold a second chance to get out before further falls.

SCMP Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, January 24, 2018, and so far it has risen 0.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sucampo Pharmaceuticals fund holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the fund giving a more negative forecast for the fund. On further gains, the fund will meet resistance from the long-term Moving Average at $18.03. On a fall, the fund will find some support from the short-term average at $17.99. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sucampo Pharmaceuticals fund

Sucampo Pharmaceuticals finds support from accumulated volume at $17.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $16.99 (-5.63%) (This fund has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 18 days ago.)

Trading Expectations (SCMP) For The Upcoming Trading Day Of Wednesday 21st

For the upcoming trading day on Wednesday, 21st we expect Sucampo Pharmaceuticals to open at $18.00, and during the day (based on 14 day Average True Range), to move between $17.94 and $18.06, which gives a possible trading interval of +/-$0.125 (+/-0.70%) up or down from last closing price. If Sucampo Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $17.98 (0.14%) than the resistance at $18.05 (0.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Sucampo Pharmaceuticals fund A Buy?

Sucampo Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.190 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on February 21, 2018 - $18.00 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SCMP Performance

Trading levels for SCMP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 18.00 -
R2 18.00 -
R1 18.00 -
Price 18.00
S1 18.00 -
S2 18.00 -
S3 18.00 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 18.40 2.22%
R2 18.15 0.83%
R1 18.05 0.278%
Price 18.00
S1 17.98 -0.139%
S2 17.95 -0.278%
S3 16.75 -6.94%

FAQ

What is the symbol for Sucampo Pharmaceuticals Fund and on which exchange is it traded?
The symbol for Sucampo Pharmaceuticals is SCMP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sucampo Pharmaceuticals Fund?
Sucampo Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Sucampo Pharmaceuticals Fund?
Sucampo Pharmaceuticals Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sucampo Pharmaceuticals Fund.

What's the current price of Sucampo Pharmaceuticals Fund?
As of the end of day on the Feb 20, 2018, the price of an Sucampo Pharmaceuticals (SCMP) share was $18.00.

What is the 52-week high and low for Sucampo Pharmaceuticals Fund?
The 52-week high for Sucampo Pharmaceuticals Fund is $18.75 and the 52-week low is $9.30.
Click to get the best stock tips daily for free!
ABOUT SUCAMPO PHARMACEUTICALS
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research and development of proprietary drugs for the treatment of gastrointestinal, ophthalmic, autoimmune, and oncology-based inflammatory disorders in the United States, Japan, Switzerland, and internationally. The company’s marketed product includes AMITIZA, a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation in adults; irritable bo...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE